Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Quantum-Si Incorporated - Class A Common Stock (NQ:QSI)

0.8744 +0.0082 (+0.95%)
Streaming Delayed Price Updated: 10:24 AM EDT, Jul 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Quantum-Si Incorporated - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces the Expansion of the Proteus™ Roadshow
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces New Manuscript Demonstrating the Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces First Customer Samples Tested on the Proteus™ Prototype System
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces the Start of the Proteus™ Roadshow
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces the Release of Two New Manuscripts Demonstrating the Value of Single-Molecule Protein Sequencing in Clinical Proteomics and Pathogen & Toxin Detection
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company’s Industry Leading Technology Pipeline at Investor & Analyst Day
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Reports Third Quarter 2025 Financial Results
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.